These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
614 related items for PubMed ID: 33229509
21. Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis. Lee JH, Kim B, Jin WJ, Kim HH, Ha H, Lee ZH. Arthritis Res Ther; 2017 Jul 19; 19(1):163. PubMed ID: 28724396 [Abstract] [Full Text] [Related]
22. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. Loiseau C, Requena M, Nayrac M, Mavigner M, Cazabat M, Iscache AL, Carrere N, Suc B, Alric L, Izopet J, Delobel P. J Infect Dis; 2019 Jul 31; 220(5):830-840. PubMed ID: 30880342 [Abstract] [Full Text] [Related]
23. A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis. Morandi F, Ferretti E, Bocca P, Prigione I, Raffaghello L, Pistoia V. PLoS One; 2010 Jul 23; 5(7):e11763. PubMed ID: 20668702 [Abstract] [Full Text] [Related]
24. The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease. Haghbin M, Rostami-Nejad M, Forouzesh F, Sadeghi A, Rostami K, Aghamohammadi E, Asadzadeh-Aghdaei H, Masotti A, Zali MR. Medicine (Baltimore); 2019 Jun 23; 98(25):e15949. PubMed ID: 31232926 [Abstract] [Full Text] [Related]
25. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. Christensen JE, de Lemos C, Moos T, Christensen JP, Thomsen AR. J Immunol; 2006 Apr 01; 176(7):4235-43. PubMed ID: 16547260 [Abstract] [Full Text] [Related]
26. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. Wuest TR, Carr DJ. J Immunol; 2008 Dec 01; 181(11):7985-93. PubMed ID: 19017990 [Abstract] [Full Text] [Related]
27. Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3. Nedjai B, Li H, Stroke IL, Wise EL, Webb ML, Merritt JR, Henderson I, Klon AE, Cole AG, Horuk R, Vaidehi N, Pease JE. Br J Pharmacol; 2012 Jun 01; 166(3):912-23. PubMed ID: 21895630 [Abstract] [Full Text] [Related]
28. [Clinicopathological characteristics of the CD8+ T lymphocytes infiltration and its mechanism in distinct molecular subtype of medulloblastoma]. Chai X, Sun Z, Li H, Zhu L, Liu X, Liu Y, Pei F, Chang Q. Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun 18; 56(3):512-518. PubMed ID: 38864138 [Abstract] [Full Text] [Related]
29. Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model. Satooka H, Ishigaki H, Todo K, Terada K, Agata Y, Itoh Y, Ogasawara K, Hirata T. Sci Rep; 2020 May 21; 10(1):8414. PubMed ID: 32439888 [Abstract] [Full Text] [Related]
30. Involvement and prognosis value of CD8(+) T cells in giant cell arteritis. Samson M, Ly KH, Tournier B, Janikashvili N, Trad M, Ciudad M, Gautheron A, Devilliers H, Quipourt V, Maurier F, Meaux-Ruault N, Magy-Bertrand N, Manckoundia P, Ornetti P, Maillefert JF, Besancenot JF, Ferrand C, Mesturoux L, Labrousse F, Fauchais AL, Saas P, Martin L, Audia S, Bonnotte B. J Autoimmun; 2016 Aug 21; 72():73-83. PubMed ID: 27236507 [Abstract] [Full Text] [Related]
31. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. Cox JH, Dean RA, Roberts CR, Overall CM. J Biol Chem; 2008 Jul 11; 283(28):19389-99. PubMed ID: 18411283 [Abstract] [Full Text] [Related]
32. Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. Bondar C, Araya RE, Guzman L, Rua EC, Chopita N, Chirdo FG. PLoS One; 2014 Jul 11; 9(2):e89068. PubMed ID: 24586509 [Abstract] [Full Text] [Related]
33. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. Flier J, Boorsma DM, van Beek PJ, Nieboer C, Stoof TJ, Willemze R, Tensen CP. J Pathol; 2001 Aug 11; 194(4):398-405. PubMed ID: 11523046 [Abstract] [Full Text] [Related]
34. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4+ T Cell Migration and Is Regulated by the Viral Immediate-Early Protein ICP4. Zhang M, Deng X, Guan X, Geng L, Fu M, Zhang B, Chen R, Hu H, Hu K, Zhang D, Li M, Liu Y, Gong S, Hu Q. Front Immunol; 2018 Aug 11; 9():2932. PubMed ID: 30619292 [Abstract] [Full Text] [Related]
38. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ]. Lin Q, Song Y, Zhu X, Yang S, Zheng J. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb 11; 29(2):137-40. PubMed ID: 23388331 [Abstract] [Full Text] [Related]
39. The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart. Altara R, Mallat Z, Booz GW, Zouein FA. J Immunol Res; 2016 Feb 11; 2016():4396368. PubMed ID: 27795961 [Abstract] [Full Text] [Related]
40. Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3. Scholten DJ, Canals M, Wijtmans M, de Munnik S, Nguyen P, Verzijl D, de Esch IJ, Vischer HF, Smit MJ, Leurs R. Br J Pharmacol; 2012 Jun 11; 166(3):898-911. PubMed ID: 21883151 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]